Novo Nordisk Ltd

About us ...

Novo Nordisk has the broadest diabetes product portfolio in the industry. We also have a leading position in areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.

 

 

 

IC/CGFF/SGUA
Last updated: 12 February 2008

 

Full year results

See the CNBC Europe interview with our president and CEO, Lars Rebien Sørensen.